Anebulo Pharmaceuticals

Anebulo lifts lid on midphase cannabis intoxication therapy data, teeing up further development
Fierce Biotech
Mon, 09/26/22 - 10:53 am
Anebulo Pharmaceuticals
clinical trials
ANEB-001
anti-cannabinoid intoxication
Rain Therapeutics headlines newest slate of IPO-bound biotechs with $100M penciled in for lead oncology program
Endpoints
Mon, 04/5/21 - 10:21 pm
IPOs
Rain Therapeutics
Impel NeuroPharma
Anebulo Pharmaceuticals